pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 102

Genome Genomics Medicine Development 102

Drug Discovery World

JANUARY 19, 2023

This paid-for advertorial by Sphere Fluidics appeared in the SLAS 2023 Supplement, Volume 24 – Issue 1, Winter 2022/2023 Cell engineering is being held back by lengthy and complicated multi-step workflows. Sphere Fluidics’ Cyto-Mine ® system offers a streamlined, automated solution to this challenge using picodroplet microfluidic technology.

Engineer 52

Engineer Bioassay Life Science Genome 52

Drug Discovery World

FEBRUARY 20, 2023

“GenScript is pleased to partner with Indee Labs to advance the development of novel RNP and oligo delivery systems for non-viral CRISPR cell engineering,” said Ray Chen, PhD, president of GenScript’s Life Science Group.

Engineer 52

Engineer DNA Life Science Gene 52

Drug Discovery World

JANUARY 17, 2024

ERS Genomics, a CRISPR/Cas9 licensing company, and StemSight, a biotechnology company developing stem cell based therapies for corneal blindness, have entered a non-exclusive CRISPR/Cas9 license agreement. This collaboration underscores the growing prominence of Finland, and the Nordics, in the global biotechnology and life science sector.

Licensing 52

Licensing Licensing Genome Genomics 52

The Pharma Data

JANUARY 31, 2021

(NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Genome 52

Genome Genomics Life Science DNA 52

XTalks

DECEMBER 24, 2020

The pandemic propelled the life science and healthcare sectors onto center stage, and they rose to the occasion against the most unprecedented health challenge in recent times. While COVID-19 has undoubtedly been the biggest story in the life science industry in 2020, it was a busy and positive year in many other areas.

Life Science 111

Life Science Vaccination Vaccine Gene 111

Drug Discovery World

FEBRUARY 12, 2024

Leslie Orne, President and CEO, Trinity Life Sciences “AI and ML will play an increasingly important role in the clinical development and commercialisation of cell and gene therapies, which are typically targeted to small patient populations.

Genome 139

Genome Genomics Life Science Gene Therapy 139

Drug Discovery World

MAY 5, 2023

Eterna Therapeutics, a life science company focused on mRNA cell engineering, has acquired Exacis Biotherapeutics’ immuno-oncology platform. Eterna plans to use Exacis’ platform to develop engineered cell therapies containing genomic edits designed to enhance their performance.

Gene Editing 52

Gene Editing Engineer DNA Life Science 52

BioTech 365

NOVEMBER 2, 2020

Addition of CRISPR and RNAi offerings to complement PerkinElmer’s life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine WALTHAM, Mass.–(BUSINESS –(BUSINESS WIRE)–PerkinElmer, Inc.

Engineer 52

Engineer Life Science Genome Genomics 52

Drug Discovery World

FEBRUARY 6, 2024

Scientific sessions Tuesday’s presentations spanned a range of topics, including functional genomics for target identification, next-generation proteomics, self-driving laboratories, the future of cell culture, and ‘lab on a particle’ technology.

Life Science 64

Life Science Genome Genomics RNA 64

Drug Discovery World

NOVEMBER 27, 2023

By Anis H Khimani , PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Upstream cell line development has seen notable progress with recent advances in cell line engineering, particularly in enhancing gene of interest integration specificity, clone selection, and production efficiency.

Production 59

Production Engineer Gene Editing Gene 59

XTalks

AUGUST 29, 2022

CRISPR is notable for engineering living cells, allowing scientists to edit, turn off, delete, or replace genes in a cell’s genome. It is difficult to control where the viral vectors insert genes in the genome, and it is difficult to manufacture large quantities of clinical-grade viral vectors.

Gene Editing 98

Gene Editing DNA Gene Genome 98

Pharmaceutical Technology

FEBRUARY 13, 2023

About 30% of epilepsy patients do not respond to available anti-seizure treatments, says Dr. Dario Englot, director of functional neurosurgery at Vanderbilt University’s Institute for Surgery and Engineering in Nashville, Tennessee. SK Life Science is a subsidiary of SK, a South Korean holding company.

Research 264

Research Gene Gene Therapy Genome 264

Drug Discovery World

MAY 29, 2024

Sartorius and NVIDIA Sartorius is expanding its multidisciplinary collaboration with NVIDIA combining Sartorius’ knowledge of life sciences and bioprocessing with NVIDIA’s AI-powered computing platforms and software. Sartorius has been working with NVIDIA since 2020. “Biological interactions are exceptionally complex.

Drugs 52

Drugs Gene Editing Life Science Genome 52

Pharmaceutical Technology

JUNE 4, 2023

AAV genomes are highly compact, with overlapping coding regions, alternate splicing schemes, and multiple transcription initiation codons. There are two main genes in the AAV genome, rep and cap, which encode nine different proteins.

Gene 262

Gene Gene Therapy Genetics DNA 262

XTalks

APRIL 5, 2021

Bioinformatics jobs are commonly found in the fields of computer information science, pharmaceuticals, biotechnology, medical technology, computational biology, proteomics and medical informatics. The Human Genome Project could not have succeeded without the use of bioinformatics. Wondering which bioinformatics job is right for you?

Bioinformatics 59

Bioinformatics Engineer Scientist Genome 59

Drug Discovery World

OCTOBER 16, 2023

Maina Bhaman, Partner at Sofinnova Partners, says: “The UK is an attractive space for drug discovery companies and a prime environment for investment due to its talent, infrastructure, and genomics research. CellProthera also appointed the Newcastle Centre for Life’s GMP cell therapy centre to produce the ATMP.”

Drugs 75

Drugs Life Science Gene Therapy Genome 75

Drug Discovery World

JULY 11, 2023

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

Big Data 40

Big Data Development Life Science Drugs 40

Drug Discovery World

JANUARY 26, 2023

Colin Terry, European Life Sciences R&D leader at Deloitte, explains: “Revitalising today’s clinical trials processes and operations will drastically improve trial efficiency, enhance science-based decisions, and expand collective health equity.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Drug Discovery World

MAY 25, 2023

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. DDW provides an update.

Production 52

Production Reagent DNA Drugs 52

XTalks

MAY 4, 2021

The tool could also prove to be safer than conventional CRISPR-based gene therapies as it does not involve DNA editing, and thus would not cause potentially harmful off-target genomic changes. Related: 2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences. Epigenetic Editing with CRISPR.

DNA 98

DNA Gene Gene Silencing Genome 98

Drug Discovery World

NOVEMBER 1, 2023

DDW’s Diana Spencer meets Dr Stephen Jones, Research Professor and Group Leader at the EMBL Partnership Institute for Genome Editing Technologies at Vilnius University’s Life Sciences Center. DS: Can you tell us what you do and what you’re working on at the moment? DS: What’s been the highlight of your career so far?

Gene Editing 59

Gene Editing Research Gene Genome 59

pharmaphorum

DECEMBER 9, 2022

The 11 new graduates – which join 12 who completed the programme earlier in the year – are as follows: Biostrap , an Austin, Texas startup that has developed a biosensor-based digital biomarker platform for remote physiological monitoring; Lincoln, Massachusetts-based Celero Systems , pioneering an ingestible pill-like device that can discreetly monitor (..)

Life Science 52

Life Science DNA Genome Genomics 52

The Pharma Data

JANUARY 17, 2021

Syntegra’s synthetic data engine will be a key component of the National COVID Cohort Collaborative (N3C), validating the generation of a non-identifiable synthetic version of the entire dataset, representing 2.7m+ screened individuals, including over 413,000 COVID-19 positive patients, and 2.6B rows of data. rows of data.

Life Science 52

Life Science Engineer Big Data Scientist 52

Drug Discovery World

FEBRUARY 6, 2024

Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and Insilico Medicine used an AI target discovery engine to analyse transcriptomic data to identify dual targets for cancer and ageing 5. Digital tech is also helping researchers to find target candidates for some of the most challenging disease areas.

Marketing 69

Marketing Medicine Genome Genomics 69

XTalks

MARCH 28, 2024

Building Cancer Awareness and Empowering Métis Youth: Featuring Jordyn Playne, President, Métis Nation of Ontario Youth Council – Xtalks Life Science Podcast Ep. Gene Editing and CAR T-Cell Therapy Genetic engineering technologies, such as CRISPR-Cas9, are providing newer potential avenues for cancer treatment.

Gene Editing 59

Gene Editing Life Science Clinical Trials Clinical Trials 59

XTalks

MAY 20, 2022

Depending on the type of field or company, you can pursue clinical scientist jobs with a major in biology, medicine, medical technology, chemistry, immunology and other related life science and pre-medical degrees. Below is a brief preview from the National Health Services’ list of healthcare science fields: Vascular Science.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

pharmaphorum

MARCH 16, 2021

There are a good number of use cases as to why pretty much every big life science company is choosing us these days,” says Medrano. Life sciences companies are interested in understanding the behaviour of the patients and the pathologies where they are working. AI use in the pandemic.

Doctors 113

Doctors Doctor Life Science Clinical Research 113

Pharmaceutical Technology

MAY 8, 2023

Innovation S-curve for the pharmaceutical industry Zinc-finger nucleases is a key innovation area in pharmaceutical Zinc finger nucleases (ZFNs) are tools used in genetic engineering to cleave a chosen genomic sequence.

Genetics 130

Genetics DNA Genetic Engineering Antibody 130

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — Caris Life Sciences® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Winship Cancer Institute of Emory University (Winship) has joined Caris’ Precision Oncology Alliance (The Alliance/POA). .”

Life Science 52

Life Science Clinical Trials Clinical Trials RNA 52

Drug Discovery World

OCTOBER 5, 2022

It’s an incredibly exciting time in the life sciences – with a focus on collaboration across disciplines the sky is the limit and the opportunities to create diagnostic tools and therapeutics that could benefit society as a whole are innumerable. Q: What do you see as being the driver for the renaissance in the life sciences? .

Life Science 52

Life Science Medicine Drugs Genome 52

XTalks

MAY 4, 2021

The tool could also prove to be safer than conventional CRISPR-based gene therapies as it does not involve DNA editing, and thus would not cause potentially harmful off-target genomic changes. Related: 2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences. Epigenome Editing with CRISPR.

DNA 52

DNA Gene Gene Silencing Genome 52

XTalks

OCTOBER 20, 2023

Clinical-stage genome editing company Intellia Therapeutics has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to start a pivotal phase III trial of NTLA-2001 for the treatment of transthyretin (ATTR) amyloidosis with cardiomyopathy.

In-Vivo 52

In-Vivo Gene Editing Trials Gene 52

pharmaphorum

NOVEMBER 11, 2020

With AI already the key engine for a growing list of consumer devices, the trend has created exciting opportunities for pharma and healthcare. “We For pharmaceutical companies, artificial intelligence can help spur drug discovery through finding complex relationships within genomics data.

Engineer 129

Engineer Life Science Genome Genomics 129

XTalks

JANUARY 2, 2024

Upon Vyjuvek’s entry into cells, the vector genome is integrated into the nucleus, initiating the transcription of the encoded human COL7A1. EB-101, an engineered cell therapy for RDEB, demonstrated a substantial improvement in wound healing (81.4 percent) compared to the control group (16.3 percent) at the six-month mark.

FDA Approval 111

FDA Approval Gene Therapy Gene Trials 111

Drug Discovery World

MAY 26, 2023

Biotech data, largely fueled by genomics, is doubling every seven months in size, making biotech the industry with the largest data volume by 2025. But data science and and data modeling are relatively new skillsets. Develop infrastructure to capture quality data AI and ML technology all starts with data.

Scientist 52

Scientist Engineer Life Science Genome 52

XTalks

OCTOBER 21, 2020

The Duke researchers developed statistical methods to identify adaptive changes that arose specifically in the SARS-CoV-2 genome in humans, but not in closely related coronaviruses found in bats and pangolins. Related: Study Dispels Claim that COVID-19-Causing Coronavirus is Lab-Engineered.

RNA 98

RNA Protein Genome Genomics 98